GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Their expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest. Its broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Vision for the future is to enable “early health” model focused on earlier diagnosis, pre-symptomatic disease detection and prevention.
Myoview™(technetium Tc-99m tetrofosmin)
A cardiac imaging agent, is useful in the diagnosis and localization of regions of reversible myocardial ischemia in the presence or absence of infarction under exercise and rest conditions.
Ceretec™(technetium Tc-99m exametazime)
An imaging agent with 2 distinct indications. One is for visualization of cerebral blood flow. The other is for labeling of white blood cells to localize sites of infection and inflammation.
Metastron™(strontium-89 chloride injection)
An intravenously administered radioisotope that provides pain relief for patients suffering from bone pain due to metastatic prostate cancer. The active agent, strontium-89, is a calcium analogue and, when injected into bloodstream, targets area where calcium uptake is seen, including growing bone cancer.